US Child Flu Deaths Surge
Analysis based on 6 articles · First reported May 02, 2025 · Last updated May 03, 2025
The severe flu season in the United States, marked by a significant increase in pediatric deaths and declining vaccination rates, could negatively impact the healthcare and pharmaceutical industries. Increased hospitalizations and illnesses may strain healthcare resources, while reduced vaccine uptake could affect pharmaceutical companies producing flu vaccines.
The United States is experiencing its deadliest flu season for children in 15 years, with 216 pediatric deaths reported by the United States — Centers for Disease Control and Prevention, surpassing the 207 deaths last year. This number is expected to rise as the flu season is still ongoing. Experts, including Seán O Leary of the American Academy of Pediatrics, attribute the severity partly to a plummeting flu vaccination rate among U.S. children, which has fallen from 64% five years ago to 49% this season. The season has also been severe for adults, with an estimated 47 million illnesses, 610,000 hospitalizations, and 26,000 deaths. The decline in childhood vaccinations is linked to online misinformation and political divisions around COVID-19 vaccines, with figures like Robert F. Kennedy Jr. echoing anti-vaccine sentiments. Despite waning flu indicators since February, the United States — Centers for Disease Control and Prevention continues to recommend annual flu vaccines for everyone aged 6 months and older.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard